TP53 and nonpapillary renal cell carcinoma: LFs were also related to the presence of ccRCC somatic cancer driver mutations, of which associations with PBRM1, SETD2, BAP1, and TP53 were replicated in the validation phase (Figs. 2C and EV3C).